Want to see AU:ZNO full AI Analyst Report?
Top Page
Zoono Group Limited
(Sydney:ZNO)
Select Model
Select Model
Rating:46Neutral
Price Target:
AU$0.05
▼(-38.75% Downside)
Action:Reiterated
Date:08/28/26
The score is held down primarily by continued multi-year losses and persistent negative operating/free cash flow, despite a notable 2026 rebound in revenue and gross margin. Technicals also remain soft, with the price below key longer-term moving averages and negative MACD. Valuation offers limited support because the negative P/E reflects ongoing unprofitability and no dividend yield is provided.
Positive Factors
Revenue Rebound
The strong 2026 revenue rebound indicates renewed product demand and improved commercial traction. If sustained, higher sales can broaden market reach, support distribution expansion, and provide a larger base for eventual operating leverage.
Negative Factors
Persistent Losses
Five consecutive loss-making years show that revenue growth has not yet translated into a sustainable earnings model. The deeply negative 2026 net margin indicates substantial operating or other costs remain, limiting financial resilience and reinvestment capacity.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Rebound
The strong 2026 revenue rebound indicates renewed product demand and improved commercial traction. If sustained, higher sales can broaden market reach, support distribution expansion, and provide a larger base for eventual operating leverage.
Read all positive factors
Zoono Group Limited (ZNO) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$19.09M
Dividend Yield2.08%
Average Volume (3M)58.13K
Price to Earnings (P/E)―
Beta (1Y)0.40
Revenue Growth28.77%
EPS Growth60.40%
CountryAU
Employees2
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding406,211,760
10 Day Avg. Volume28,518
30 Day Avg. Volume58,128
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)7.42
Price to Sales (P/S)14.50
P/FCF Ratio-16.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Zoono Group Limited Business Overview & Revenue Model
Company Description
Zoono Group Limited, along with its associated entities, specializes in the innovation, development, and global distribution of a variety of antimicrobial solutions, catering to both the New Zealand market and international clientele. Their produc...
How the Company Makes Money
Zoono primarily makes money by selling antimicrobial and sanitising products (including surface sanitiser and hand sanitiser formats) under its brand, generating revenue when these products are ordered by commercial customers and distributed into ...
Zoono Group Limited Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
56
Neutral
Cash Flow
22
Negative
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.49M | 1.16M | 960.30K | 3.07M | 8.13M |
| Gross Profit | 595.90K | -281.53K | -4.36M | -625.33K | 2.10M |
| EBITDA | -1.22M | -3.26M | -7.89M | -181.62K | -5.11M |
| Net Income | -1.59M | -3.64M | -8.30M | -321.97K | -10.28M |
Balance Sheet | |||||
| Total Assets | 5.28M | 5.87M | 9.01M | 13.40M | 17.68M |
| Cash, Cash Equivalents and Short-Term Investments | 220.15K | 47.30K | 1.79M | 759.99K | 3.30M |
| Total Debt | 298.54K | 544.56K | 726.63K | 868.36K | 1.00M |
| Total Liabilities | 2.37M | 2.89M | 2.76M | 3.24M | 8.41M |
| Stockholders Equity | 2.91M | 2.97M | 6.24M | 10.16M | 10.00M |
Cash Flow | |||||
| Free Cash Flow | -1.33M | -1.58M | -2.89M | -3.55M | -996.61K |
| Operating Cash Flow | -1.33M | -1.58M | -2.89M | -3.55M | -974.11K |
| Investing Cash Flow | -349.00 | 0.00 | -58.73K | -53.49K | -107.62K |
| Financing Cash Flow | 1.50M | -190.15K | 3.99M | 873.62K | -54.99K |
Zoono Group Limited Technical Analysis
Negative
0.08
Price Trends
0.05
Negative
0.06
Negative
0.06
Negative
Market Momentum
>-0.01
Negative
42.92
Neutral
100.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ZNO, the sentiment is Negative. The current price of 0.08 is above the 20-day moving average (MA) of 0.05, above the 50-day MA of 0.05, and above the 200-day MA of 0.06, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 42.92 is Neutral, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:ZNO.
Zoono Group Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
46 Neutral | AU$19.09M | -11.75 | -50.40% | 2.08% | 28.77% | 60.40% | |
44 Neutral | AU$5.28M | -2.34 | -49.07% | ― | -33.53% | 42.98% | |
43 Neutral | AU$17.99M | -0.86 | -33.14% | 4.92% | -14.87% | -35.60% | |
41 Neutral | AU$3.92M | -1.10 | -43.04% | 221.43% | -29.84% | 22.51% | |
41 Neutral | AU$12.13M | -0.67 | -430.23% | ― | -50.64% | -72.00% |
* Consumer Defensive Sector Average
AU:ZNO
Zoono Group Limited
0.05
0.02
46.88%
AU:PTL
Pental Ltd.
0.02
-0.03
-55.77%
AU:MCP
Mcpherson'S Limited
0.12
-0.14
-53.85%
AU:EVE
EVE Health Group Limited
0.02
-0.02
-50.00%
AU:SKN
Skin Elements Limited
―
―
―
Zoono Group Limited Corporate Events
Zoono lodges updated ASX corporate governance statement for FY26
Aug 27, 2026
Zoono Group Limited has lodged its updated corporate governance statement for the year ended 30 June 2026 and confirmed it is available on the company’s investor website. The statement, current as of 27 August 2026 and approved by the board,...
Zoono Narrows Annual Loss as Revenue Rises but Keeps Dividend on Hold
Aug 27, 2026
Zoono Group Limited reported a 37.9% increase in revenues from ordinary activities to NZ$1.72 million for the year ended 30 June 2026, while significantly narrowing its loss after tax. The loss attributable to owners fell by around half to NZ$1.84...
Zoono posts strong FY27 start on shelf-life orders and online sales
Aug 3, 2026
Zoono Group Limited has reported a strong start to its FY27 financial year, driven by continuing shelf-life extension orders that delivered unaudited July sales of about NZ$625,000 and an unaudited profit of NZ$110,000. The company also noted impr...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.